Market Research Logo

Europe Candidiasis Market and Competitive Landscape – 2017

Europe Candidiasis Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Europe Candidiasis Market and Competitive Landscape – 2017, provides comprehensive insights into Candidiasis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Candidiasis market size and drug sales. This research also provides insights into Candidiasis epidemiology and late stage pipeline.
The report is classified into nine sections – Candidiasis overview with definitions, symptoms, etiology, diagnosis, treatment options; Candidiasis pipeline insights covering late stage clinical trials pipeline; Candidiasis prevalence trends by countries; Candidiasis market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries – Germany, France, Italy, Spain, UK, Europe.

Research Scope:

  • Candidiasis pipeline: Find out the drugs in clinical trials for Candidiasis by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Candidiasis epidemiology: Find out the prevalence of Candidiasis by countries – Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Candidiasis products: Identify key products marketed and prescribed for Candidiasis by brand name, by molecule, by company, by branded / generic, by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Candidiasis market size: Find out the market size for Candidiasis drugs by countries – Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Candidiasis drug sales: Find out the sales of Candidiasis drugs by countries – Europe, Germany, France, Italy, Spain, UK
  • Candidiasis drugs sales forecast: Sales forecast for Candidiasis drugs to 2021 by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Candidiasis market share analysis: Find out the market shares of Candidiasis drugs and outlook by countries – Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Candidiasis drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Candidiasis market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Candidiasis market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


1. Candidiasis: Disease Overview
1.1. Candidiasis Symptoms
1.2. Candidiasis Etiology
1.3. Candidiasis Diagnosis
1.4. Candidiasis Treatment Options
2. Candidiasis Pipeline Insights
2.1. Candidiasis Phase 3 Clinical Trials
2.2. Candidiasis Phase 2 Clinical Trials
2.3. Candidiasis Phase 1 Clinical Trials
3. Candidiasis Epidemiology Analysis
4. Germany Candidiasis Market Insights
4.1. Marketed Products for Candidiasis in Germany
4.2. Germany Candidiasis Market Size & Forecast
4.3. Germany Candidiasis Product Sales Forecast
4.4. Germany Candidiasis Market Share Analysis
5. France Candidiasis Market Insights
5.1. Marketed Products for Candidiasis in France
5.2. France Candidiasis Market Size & Forecast
5.3. France Candidiasis Product Sales Forecast
5.4. France Candidiasis Market Share Analysis
6. Italy Candidiasis Market Insights
6.1. Marketed Products for Candidiasis in Italy
6.2. Italy Candidiasis Market Size & Forecast
6.3. Italy Candidiasis Product Sales Forecast
6.4. Italy Candidiasis Market Share Analysis
7. Spain Candidiasis Market Insights
7.1. Marketed Products for Candidiasis in Spain
7.2. Spain Candidiasis Market Size & Forecast
7.3. Spain Candidiasis Product Sales Forecast
7.4. Spain Candidiasis Market Share Analysis
8. UK Candidiasis Market Insights
8.1. Marketed Products for Candidiasis in UK
8.2. UK Candidiasis Market Size & Forecast
8.3. UK Candidiasis Product Sales Forecast
8.4. UK Candidiasis Market Share Analysis
9. Europe Candidiasis Market Insights
9.1. Europe Candidiasis Market Size & Forecast
9.2. Europe Candidiasis Product Sales Forecast
9.3. Europe Candidiasis Market Share Analysis
10. Research Methodology
LIST OF TABLES
Table 1: Candidiasis Phase 3 Clinical Trials, Global, 2017
Table 2: Candidiasis Phase 2 Clinical Trials, Global, 2017
Table 3: Candidiasis Phase 1 Clinical Trials, Global, 2017
Table 4: Candidiasis Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Candidiasis in Germany, 2017
Table 6: Germany Candidiasis Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Candidiasis Product Sales ($mn), 2012 - 2021
Table 8: Germany Candidiasis Market Trends, 2012 - 2021
Table 9: Marketed Products for Candidiasis in France, 2017
Table 10: France Candidiasis Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Candidiasis Product Sales ($mn), 2012 - 2021
Table 12: France Candidiasis Market Trends, 2012 - 2021
Table 13: Marketed Products for Candidiasis in Italy, 2017
Table 14: Italy Candidiasis Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Candidiasis Product Sales ($mn), 2012 - 2021
Table 16: Italy Candidiasis Market Trends, 2012 - 2021
Table 17: Marketed Products for Candidiasis in Spain, 2017
Table 18: Spain Candidiasis Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Candidiasis Product Sales ($mn), 2012 - 2021
Table 20: Spain Candidiasis Market Trends, 2012 - 2021
Table 21: Marketed Products for Candidiasis in UK, 2017
Table 22: UK Candidiasis Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Candidiasis Product Sales ($mn), 2012 - 2021
Table 24: UK Candidiasis Market Trends, 2012 - 2021
Table 25: Europe Candidiasis Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Candidiasis Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Candidiasis Pipeline by Phase (%), Global, 2017
Figure 2: Candidiasis Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Candidiasis Market Size ($mn), 2012 - 2021
Figure 4: Germany Candidiasis Product Sales ($mn), 2012 - 2021
Figure 5: Germany Candidiasis Market Share by Products (%), 2016
Figure 6: Germany Candidiasis Market - Future Market Share (%), 2021
Figure 7: France Candidiasis Market Size ($mn), 2012 - 2021
Figure 8: France Candidiasis Product Sales ($mn), 2012 - 2021
Figure 9: France Candidiasis Market Share by Products (%), 2016
Figure 10: France Candidiasis Market - Future Market Share (%), 2021
Figure 11: Italy Candidiasis Market Size ($mn), 2012 - 2021
Figure 12: Italy Candidiasis Product Sales ($mn), 2012 - 2021
Figure 13: Italy Candidiasis Market Share by Products (%), 2016
Figure 14: Italy Candidiasis Market - Future Market Share (%), 2021
Figure 15: Spain Candidiasis Market Size ($mn), 2012 - 2021
Figure 16: Spain Candidiasis Product Sales ($mn), 2012 - 2021
Figure 17: Spain Candidiasis Market Share by Products (%), 2016
Figure 18: Spain Candidiasis Market - Future Market Share (%), 2021
Figure 19: UK Candidiasis Market Size ($mn), 2012 - 2021
Figure 20: UK Candidiasis Product Sales ($mn), 2012 - 2021
Figure 21: UK Candidiasis Market Share by Products (%), 2016
Figure 22: UK Candidiasis Market - Future Market Share (%), 2021
Figure 23: Europe Candidiasis Market Size ($mn), 2012 - 2021
Figure 24: Europe Candidiasis Product Sales ($mn), 2012 - 2021
Figure 25: Europe Candidiasis Market Share by Products (%), 2016
Figure 26: Europe Candidiasis Market - Future Market Share (%), 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report